ON THE CONTROL OF TUMOR GROWTH VIA TYPE-1 AND INTERVAL TYPE-2 FUZZY LOGIC

This paper deals with growth control of cancer cells population using type-1 and interval type-2 fuzzy logic. A type-1 fuzzy controller is designed in order to reduce the population of cancer cells, adjust the drug dosage in a manner that allows normal cells re-grow in treatment period and maintain the maximum drug delivery rate and plasma concentration of drug in an appropriate range. Two different approaches are studied. One deals with reducing the number of cancer cells without any concern about the rate of decreasing, and the other takes the rate of malignant cells damage into consideration. Due to the fact that uncertainty is an inherent part of real systems and affects controller efficacy, employing new methods of design such as interval type-2 fuzzy logic systems for handling uncertainties may be efficacious. Influence of noise on the system is investigated and the effect of altering free parameters of design is studied. Using an interval type-2 controller can diminish the effects of incomplete and uncertain information about the system, environmental noises, instrumentation errors, etc. Simulation results confirm the effectiveness of the proposed methods on tumor growth control.

[1]  Robert S. Parker,et al.  Clinically relevant cancer chemotherapy dose scheduling via mixed-integer optimization , 2009, Comput. Chem. Eng..

[2]  Paolo Magni,et al.  Predictive Pharmacokinetic-Pharmacodynamic Modeling of Tumor Growth Kinetics in Xenograft Models after Administration of Anticancer Agents , 2004, Cancer Research.

[3]  R. B. Martin,et al.  Optimal control drug scheduling of cancer chemotherapy , 1992, Autom..

[4]  Dongrui Wu,et al.  Comparison and practical implementation of type-reduction algorithms for type-2 fuzzy sets and systems , 2011, 2011 IEEE International Conference on Fuzzy Systems (FUZZ-IEEE 2011).

[5]  G. W. Swan Cancer chemotherapy: Optimal control using the Verhulst-Pearl equation , 1986 .

[6]  Oscar Castillo,et al.  Handling Uncertainty in Controllers Using Type-2 Fuzzy Logic , 2005, The 14th IEEE International Conference on Fuzzy Systems, 2005. FUZZ '05..

[7]  Oscar Montiel,et al.  Experimental study of intelligent controllers under uncertainty using type-1 and type-2 fuzzy logic , 2007, Inf. Sci..

[8]  N. Aguilar,et al.  Neural differential tracking control in cancer model , 2006, 2006 American Control Conference.

[9]  John M. Harrold,et al.  MODEL-BASED DESIGN OF CANCER CHEMOTHERAPY TREATMENT SCHEDULES , 2005 .

[10]  Amir Reza Radmard,et al.  Five common cancers in Iran. , 2010, Archives of Iranian medicine.

[11]  Ami Radunskaya,et al.  A mathematical tumor model with immune resistance and drug therapy: an optimal control approach , 2001 .

[12]  A. Ghaffari,et al.  Mathematical Modeling and Lyapunov-Based Drug Administration in Cancer Chemotherapy , 2009 .

[13]  A. G. Floares,et al.  Adaptive neural networks control of drug dosage regimens in cancer chemotherapy , 2003, Proceedings of the International Joint Conference on Neural Networks, 2003..

[14]  Jon Ernstberger,et al.  OPTIMAL CONTROL APPLIED TO IMMUNOTHERAPY , 2003 .

[15]  Hamid Khaloozadeh,et al.  The optimal dose of CAF regimen in adjuvant chemotherapy for breast cancer patients at stage IIB. , 2008, Mathematical biosciences.

[16]  Ali Montazeri,et al.  Breast Cancer in Iran: An Epidemiological Review , 2007, The breast journal.

[17]  Hiok Chai Quek,et al.  A novel cognitive interpretation of breast cancer thermography with complementary learning fuzzy neural memory structure , 2007, Expert Systems with Applications.

[18]  M. MendelJ. Type-2 Fuzzy Sets and Systems , 2007 .

[19]  Raj Jena,et al.  Optimal dosing of cancer chemotherapy using model predictive control and moving horizon state/parameter estimation , 2012, Comput. Methods Programs Biomed..

[20]  H. Khaloozadeh,et al.  Optimal Fuzzy Dosage Programming for Patients Suffering from Breast Cancer in Stage IIB , 2008, 2008 Cairo International Biomedical Engineering Conference.

[21]  HR Ramezanpour,et al.  A Novel Scheme for Optimal Control of a Nonlinear Delay Differential Equations Model to Determine Effective and Optimal Administrating Chemotherapy Agents in Breast Cancer , 2011, Iranian journal of cancer prevention.

[22]  E. Y. K. Ng,et al.  Application of K- and Fuzzy c-Means for Color Segmentation of Thermal Infrared Breast Images , 2010, Journal of Medical Systems.